PL1889059T3 - Uproszczone sposoby prowadzenia testów immunologicznych - Google Patents

Uproszczone sposoby prowadzenia testów immunologicznych

Info

Publication number
PL1889059T3
PL1889059T3 PL06744011T PL06744011T PL1889059T3 PL 1889059 T3 PL1889059 T3 PL 1889059T3 PL 06744011 T PL06744011 T PL 06744011T PL 06744011 T PL06744011 T PL 06744011T PL 1889059 T3 PL1889059 T3 PL 1889059T3
Authority
PL
Poland
Prior art keywords
immunoassay methods
improved immunoassay
antibody
improved
relats
Prior art date
Application number
PL06744011T
Other languages
English (en)
Inventor
John Forsyth Russell Robertson
Tony Barnes
Andrea Murray
Caroline Chapman
Original Assignee
Oncimmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncimmune Ltd filed Critical Oncimmune Ltd
Publication of PL1889059T3 publication Critical patent/PL1889059T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
PL06744011T 2005-05-27 2006-05-26 Uproszczone sposoby prowadzenia testów immunologicznych PL1889059T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US68542205P 2005-05-27 2005-05-27
GB0510943A GB2426581A (en) 2005-05-27 2005-05-27 Immunoassay methods
PCT/GB2006/001944 WO2006126008A2 (en) 2005-05-27 2006-05-26 Improved immunoassay methods
EP06744011A EP1889059B1 (en) 2005-05-27 2006-05-26 Improved immunoassay methods

Publications (1)

Publication Number Publication Date
PL1889059T3 true PL1889059T3 (pl) 2009-12-31

Family

ID=34834805

Family Applications (2)

Application Number Title Priority Date Filing Date
PL06744011T PL1889059T3 (pl) 2005-05-27 2006-05-26 Uproszczone sposoby prowadzenia testów immunologicznych
PL09004778T PL2073008T3 (pl) 2005-05-27 2006-05-26 Ulepszone sposoby prowadzenia testów immunologicznych

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL09004778T PL2073008T3 (pl) 2005-05-27 2006-05-26 Ulepszone sposoby prowadzenia testów immunologicznych

Country Status (19)

Country Link
US (1) US8722339B2 (pl)
EP (3) EP2073008B1 (pl)
JP (1) JP4876127B2 (pl)
KR (1) KR101400986B1 (pl)
CN (2) CN102749447B (pl)
AT (2) ATE436018T1 (pl)
AU (1) AU2006250923B2 (pl)
CA (1) CA2609793C (pl)
DE (1) DE602006007703D1 (pl)
DK (3) DK2275815T3 (pl)
ES (3) ES2458105T3 (pl)
GB (1) GB2426581A (pl)
MX (1) MX2007014815A (pl)
NO (1) NO339224B1 (pl)
PL (2) PL1889059T3 (pl)
PT (2) PT2073008E (pl)
RU (1) RU2416095C2 (pl)
SI (1) SI2073008T1 (pl)
WO (1) WO2006126008A2 (pl)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136311A (en) 1996-05-06 2000-10-24 Cornell Research Foundation, Inc. Treatment and diagnosis of cancer
GB9810040D0 (en) 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB9827228D0 (en) * 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
US20030232399A1 (en) * 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
GB2395270B (en) 2002-11-14 2006-08-16 Univ Nottingham Tumour marker proteins and uses thereof
US7858323B2 (en) 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
NZ563466A (en) 2005-05-27 2009-12-24 Oncimmune Ltd Improved immunoassay methods
EP3153860A3 (en) * 2005-12-22 2017-06-14 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
US9347945B2 (en) * 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
JP2009531324A (ja) 2006-03-20 2009-09-03 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 癌標的化のための操作された抗前立腺幹細胞抗原（ｐｓｃａ）抗体
EP2062053B1 (en) * 2006-09-13 2012-12-05 Oncimmune LTD Improved immunoassay methods
CN101632020B (zh) 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
WO2008042508A1 (en) * 2006-10-03 2008-04-10 University Of Southern California Grp78 as a predictor of responsiveness to therapeutic agents
CA2679205A1 (en) * 2007-02-23 2008-08-28 Predictive Biosciences Corporation Clinical intervention directed diagnostic methods
WO2009032949A2 (en) 2007-09-04 2009-03-12 The Regents Of The University Of California High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection
KR20180102215A (ko) 2007-11-27 2018-09-14 더 유니버시티 오브 브리티쉬 콜롬비아 관절염의 진단과 치료를 위한 14-3-3 에타 항체 및 이의 용도
GB0725239D0 (en) * 2007-12-24 2008-02-06 Oncimmune Ltd Calibrator for autoantibody assay
CN103884840A (zh) * 2008-02-21 2014-06-25 艾瑞斯国际有限公司 早期确定前列腺癌治疗后复发的方法
WO2010033069A1 (en) 2008-09-19 2010-03-25 Ridgeview Instruments Ab Method for the analysis of solid biological objects
WO2010085548A2 (en) * 2009-01-22 2010-07-29 Li-Cor, Inc. Single molecule proteomics with dynamic probes
WO2010096486A1 (en) 2009-02-17 2010-08-26 Cornell Research Foundation, Inc. Methods and kits for diagnosis of cancer and prediction of therapeutic value
WO2010102412A1 (en) * 2009-03-11 2010-09-16 Augurex Life Sciences Corporation Compositions and methods for characterizing arthritic conditions
KR20120098992A (ko) * 2009-06-23 2012-09-06 이벤투스 디아그노스틱스 이스라엘 리미티드 암의 검출을 위한 방법 및 시스템
CN101762700A (zh) * 2009-06-24 2010-06-30 北京科美东雅生物技术有限公司 一种定量检测血液中癌胚抗原的磁性免疫层析试纸条及制备方法
CA2768398C (en) 2009-07-24 2020-01-07 Rhode Island Hospital Dendritic cell vaccines for asparaginyl-.beta.-hydroxylase expressing tumors
MX2012004877A (es) * 2009-10-26 2012-05-23 Prometheus Lab Inc Analisis para la deteccion de farmacos anti-tnf y autoanticuerpos.
EP2506876B1 (en) 2009-12-02 2016-10-12 Imaginab, Inc. J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
EP3450979A3 (en) 2010-03-17 2019-04-24 The Regents of The University of Michigan Using phage epitopes to profile the immune response
CN102884434B (zh) 2010-05-12 2015-08-19 希尔氏宠物营养品公司 用于诊断、控制和预防犬科动物炎症及减轻犬科动物炎性病况的方法
US20130310266A1 (en) * 2010-09-03 2013-11-21 Immport Therapeutics, Inc. Methods and Compositions For The Diagnosis And Treatment Of Cancer and Autoimmune Disorders
KR101571940B1 (ko) * 2010-10-08 2015-11-25 상하이 켁신 바이오테크 씨오., 엘티디. 면역성 혈소판 감소증과 관련된 모에신 단편
EA018848B1 (ru) * 2010-10-20 2013-11-29 Вадим Юльевич ШАНИН Иммунологически активное вещество, способ его получения, биозонд на его основе и способ диагностики состояния здоровья с применением биозонда, фармацевтическая композиция и способ лечения с использованием фармацевтической композиции
CN102125698A (zh) * 2010-11-29 2011-07-20 昆明理工大学 具有正常免疫功能的小鼠移植肿瘤模型的建立方法
ES2574790T3 (es) * 2011-07-01 2016-06-22 Inova Diagnostics, Inc. Procedimiento para aumentar la especificidad de pruebas de diagnóstico para enfermedades autoinmunitarias
PT2768851T (pt) 2011-10-21 2017-09-08 Augurex Life Sciences Corp Antigénios derivados de 14-3-3 citrulinada e utilizações dos mesmos no diagnóstico de artrite reumatoide
CN102590530B (zh) * 2012-03-02 2014-06-25 常晓天 Krt84自我免疫抗体作为诊断、检测类风湿性关节炎的诊断标记物的应用
WO2013163269A1 (en) * 2012-04-24 2013-10-31 Sri International Human serum biomarkers of prostate cancer and sars-cov
EP2951592A4 (en) * 2013-01-31 2017-01-04 Arizona Board of Regents, a Body Corporate of the State of Arizona acting for and on behalf of Arizona State University Autoantibody signature for the early detection of ovarian cancer
CN103604923B (zh) * 2013-10-22 2015-05-13 卫生部北京医院 检测抗甲状腺过氧化物酶和甲状腺球蛋白的天然双特异性抗体的试剂盒
RU2678135C1 (ru) * 2014-02-05 2019-01-23 Фуджиребио Диагностикс Аб Композиция и способ для детектирования злокачественного неопластического заболевания
GB201411060D0 (en) * 2014-06-20 2014-08-06 Oncimmune Ltd Improved immunoassay method
CN104356226B (zh) * 2014-11-04 2017-03-29 青岛海兰深生物科技有限公司 一种检测血浆免疫标志物‑vegfr1自身抗体的抗原多肽及应用
WO2017027325A1 (en) 2015-08-07 2017-02-16 Imaginab, Inc. Antigen binding constructs to target molecules
US20180348221A1 (en) * 2015-12-11 2018-12-06 Sanford Health Reagents and Methods for Monitoring Breast Cancer Therapy
CN106053812B (zh) * 2016-06-29 2017-12-08 厦门生迪生物技术有限公司 一种用于肝癌早期筛查和诊断的多种自身抗体联合检测elisa试剂盒
JP6334017B1 (ja) * 2017-01-25 2018-05-30 ファナック株式会社 誘導電動機の制御装置
US11266745B2 (en) 2017-02-08 2022-03-08 Imaginab, Inc. Extension sequences for diabodies
WO2018234577A1 (en) * 2017-06-23 2018-12-27 Protagen Ag IMMUNO-ONCOLOGY FOR THE TREATMENT OF CANCER
WO2019152498A1 (en) * 2018-02-01 2019-08-08 Sedia Biosciences Corporation A rapid quantitative assay to assess duration of infection
SG10201908922UA (en) * 2019-09-25 2021-04-29 Sengenics Corp Pte Ltd Identification of health status in the elderly using immunological biomarkers
GB2600701A (en) 2020-11-04 2022-05-11 Oncimmune Ltd Antibody assay
JP7744641B2 (ja) 2020-07-14 2025-09-26 フリーノム リミテッド 肺癌における自己抗体を検出するための抗原の組合せの使用
CN112345755B (zh) * 2020-09-23 2023-06-16 杭州凯保罗生物科技有限公司 乳腺癌的生物标志物及其应用
KR102540416B1 (ko) * 2021-04-09 2023-06-12 주식회사 애티스랩 암 진단용 조성물, 키트, 및 이를 이용한 암 진단 방법
GB2622246A (en) 2022-09-08 2024-03-13 Oncimmune Germany Gmbh Antibody assay

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ211453A (en) * 1984-03-22 1989-01-06 Biotechnology Research Enterpr Aryl azides, their preparation and use in the detection, localisation and isolation of polynucleotides
EP0236606B1 (en) 1986-03-10 1992-06-24 Imre Corporation Immune complex assay
US4925788A (en) * 1986-10-24 1990-05-15 Immunicon Corporation Immunoassay system and procedure based on precipitin-like interaction between immune complex and Clq or other non-immunospecific factor
WO1989001153A1 (en) 1987-07-24 1989-02-09 Xoma Corporation Methods for breast cancer detection
US4937185A (en) * 1987-07-31 1990-06-26 The Ohio State University Research Foundation Detection of circulating antibodies to a cancer marker protein
US7282345B1 (en) * 1989-08-04 2007-10-16 Schering Ag C-erbB-2 external domain: GP75
US5157020A (en) * 1990-05-24 1992-10-20 Research Corporation Tech., Inc. Synthetic senescent cell antigen
DK9091D0 (da) 1991-01-18 1991-01-18 Novo Nordisk As Fremgangsmaade til fremstilling af antistoffer
DE4120412C1 (pl) * 1991-06-20 1993-01-07 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin, De
US6280962B1 (en) * 1991-11-25 2001-08-28 Yoreh Biotechnologies Ltd. Whole blood/mitogen assay for the early detection of a subject with cancer and kit
US6322989B1 (en) * 1991-11-25 2001-11-27 Yoreh Biotechnologies, Ltd. Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit
ATE463573T1 (de) 1991-12-02 2010-04-15 Medimmune Ltd Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
JPH07505719A (ja) * 1992-04-14 1995-06-22 デューク・ユニバーシティー ｐ５３及びＨＳＰ７０のコンプレックスを含む腫瘍の検出方法
US5801005A (en) * 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US5763164A (en) 1993-04-16 1998-06-09 Northwestern University Immunogenic cancer proteins and peptides and methods of use
US5747268A (en) * 1993-04-22 1998-05-05 Dade International Inc. Tumor marker control
CN1097252A (zh) * 1993-07-03 1995-01-11 首钢总公司 多元同步标记分析法
US5744144A (en) * 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
US5721105A (en) * 1994-02-20 1998-02-24 B.R.A.H.M.S. Diagnostica Gmbh Method for the immunological determination of proteins and kit for carrying out the method
JPH07294530A (ja) 1994-04-20 1995-11-10 Nippon Igaku Rinshiyou Kensa Kenkyusho:Kk 病原体に対する体液中の抗体検出法
CA2148971A1 (en) 1994-05-26 1995-11-27 Izak Bahar Calibrator matrix
EP0764030B1 (en) 1994-06-24 2000-09-20 Vladimir P. Torchilin Composition containing autoantibodies for tumor therapy and prophylaxis
IL110464A0 (en) 1994-07-26 1994-10-21 Univ Ramot Novel proteins for the diagnosis, imaging, and therapy of human cancer
US5561049A (en) * 1994-09-21 1996-10-01 Behringwerke Ag Method for detecting antibodies
US5876728A (en) * 1995-02-15 1999-03-02 Howard David Kass Natural composition extracted from plants used in the treatment of cancer
AUPN568095A0 (en) 1995-09-27 1995-10-26 Austin Research Institute, The Anti-Galalpha(1,3)Gal antibody binding peptides
GB9521544D0 (en) 1995-10-20 1995-12-20 Univ Dundee Activation of P53 protein and therapeutic applications thereof
JPH09189702A (ja) 1996-01-09 1997-07-22 Hitachi Chem Co Ltd 抗ムチン抗体の測定法、癌の測定法及び癌診断薬
DE69731756T2 (de) * 1996-08-16 2005-12-15 The Johns Hopkins University School Of Medicine Melanomzellinien, welche immundominante melanomantigene teilen und verfahren zu deren anwendung
CN1044092C (zh) * 1997-02-26 1999-07-14 上海医科大学 抗原－抗体－重组dna复合型疫苗
AU7713498A (en) 1997-06-03 1998-12-21 Amdl, Inc. Immunoassay for the detection of cancer
DE19805815C1 (de) * 1998-02-13 1999-11-11 Ansgar W Lohse Diagnostikum zum Erkennen der autoimmunen Hepatitis
JP4083855B2 (ja) 1998-02-16 2008-04-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 肺癌予後検査方法
GB9810040D0 (en) * 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
AUPP349098A0 (en) 1998-05-13 1998-06-04 South Eastern Sydney Area Health Service A method of monitoring pancreatic tissue viability
AU773265B2 (en) 1998-11-05 2004-05-20 Regents Of The University Of Michigan, The S100 proteins and autoantibodies as serum markers for cancer
US6387639B1 (en) * 1998-11-10 2002-05-14 Sloan-Kettering Institute For Cancer Research Ma family polypeptides and anti-Ma antibodies
GB9827228D0 (en) * 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
US7807810B2 (en) * 1999-04-08 2010-10-05 The Ohio State University Research Foundation Nucleic acids encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby
US6645465B2 (en) * 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer
US20020064801A1 (en) * 1999-12-01 2002-05-30 Ryan Jeffrey R. Novel and practical serological assay for the clinical diagnosis of leishmaniasis
US6667160B2 (en) * 2000-03-15 2003-12-23 Kenneth D. Fine Method for diagnosing immunologic food sensitivity
US20030138860A1 (en) * 2000-06-14 2003-07-24 Robertson John Forsyth Russell Cancer detection methods and reagents
US20030232399A1 (en) * 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
CA2431201A1 (en) 2000-12-13 2002-08-01 Bio-Rad Laboratories, Inc. Standard diluent for multiplex assays
AU2001271554B2 (en) * 2001-06-21 2009-03-12 New York University Mycobacterial proteins as early antigens for serodiagnosis and vaccines
GB0128583D0 (en) * 2001-11-28 2002-01-23 Rsr Ltd Detection of autoantibodies indicative of diabetes
US20030049692A1 (en) * 2002-09-16 2003-03-13 Norman Latov Detection of anti-glycolipid antibodies by latex agglutination assay
GB2395270B (en) * 2002-11-14 2006-08-16 Univ Nottingham Tumour marker proteins and uses thereof
CN1547025A (zh) * 2003-12-03 2004-11-17 刘春杰 高灵敏度酶联免疫分析检测试剂盒
JP2005352771A (ja) * 2004-06-10 2005-12-22 Hitachi Software Eng Co Ltd 発現プロファイルによるパターン認識システム
US20060141547A1 (en) * 2004-11-16 2006-06-29 Das Hasi R Novel diagnostic marker, a diagnostic kit and a method for diagnosis of rheumatoid arthritis
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
EP1789435B1 (en) * 2005-09-12 2010-02-24 Industry Foundation of Chonnam National University A method for production of mature natural killer cell
TWI304443B (en) * 2005-12-30 2008-12-21 Nat Health Research Institutes Alpha-enolase specific antibody and method of use
EP2062053B1 (en) 2006-09-13 2012-12-05 Oncimmune LTD Improved immunoassay methods
CN101632020B (zh) * 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
GB0725239D0 (en) * 2007-12-24 2008-02-06 Oncimmune Ltd Calibrator for autoantibody assay

Also Published As

Publication number Publication date
US20080305476A1 (en) 2008-12-11
AU2006250923B2 (en) 2012-06-07
EP1889059A2 (en) 2008-02-20
NO20076656L (no) 2008-02-26
JP4876127B2 (ja) 2012-02-15
SI2073008T1 (sl) 2012-08-31
RU2007149281A (ru) 2009-07-10
ATE436018T1 (de) 2009-07-15
EP2073008B1 (en) 2012-04-18
AU2006250923A1 (en) 2006-11-30
DE602006007703D1 (de) 2009-08-20
EP2275815B1 (en) 2014-04-02
US8722339B2 (en) 2014-05-13
ATE554386T1 (de) 2012-05-15
DK2275815T3 (da) 2014-05-12
KR20080034851A (ko) 2008-04-22
CN101203756A (zh) 2008-06-18
DK2073008T3 (da) 2012-06-04
ES2384935T3 (es) 2012-07-16
WO2006126008A2 (en) 2006-11-30
EP1889059B1 (en) 2009-07-08
GB2426581A (en) 2006-11-29
JP2008542703A (ja) 2008-11-27
CA2609793A1 (en) 2006-11-30
KR101400986B1 (ko) 2014-05-28
MX2007014815A (es) 2008-04-11
CA2609793C (en) 2018-05-22
PT2275815E (pt) 2014-07-10
EP2275815A3 (en) 2011-02-02
ES2458105T3 (es) 2014-04-29
CN101203756B (zh) 2016-03-09
PL2073008T3 (pl) 2012-09-28
WO2006126008A3 (en) 2007-03-29
GB0510943D0 (en) 2005-07-06
ES2328171T3 (es) 2009-11-10
NO339224B1 (no) 2016-11-21
EP2275815A2 (en) 2011-01-19
DK1889059T3 (da) 2009-11-02
CN102749447A (zh) 2012-10-24
RU2416095C2 (ru) 2011-04-10
CN102749447B (zh) 2015-05-13
EP2073008A1 (en) 2009-06-24
PT2073008E (pt) 2012-06-18

Similar Documents

Publication Publication Date Title
GB0510943D0 (en) Improved immunoassay methods
BRPI0707645B8 (pt) métodos in vitro para detecção de câncer em um indivíduo e para avaliação de prognóstico de um indivíduo tendo, ou suspeito de ter, câncer ovariano
ATE438853T1 (de) Diagnostische testvorrichtung
WO2008135564A3 (en) Assays
WO2006026020A3 (en) Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
EP3293522A3 (en) Lipidomic biomarkers for identification of high-risk coronary artery disease patients
MX2009004460A (es) Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos.
MX2007005053A (es) Metodo para evaluar la enfermedad de alzheimer y reactivo de diagnostico.
WO2005108989A3 (en) Assay for antibodies
SG179122A1 (en) Serum-based biomarkers of pancreatic cancer and uses thereof for disease detection and diagnosis
WO2009121024A3 (en) Methods for detecting antibodies
WO2008062048A3 (en) Methods for optically detecting multiple analytes in a liquid sample with a compressible microfluidic device
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
NZ592819A (en) Thyroid analyte detection and measurement
DE602006021777D1 (de) Diagnoseverfahren für präeklampsie
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
ATE469351T1 (de) Turbidimetrischer immunoassay zur beurteilung von humanem cystatin c
ATE462803T1 (de) Kit und verfahren zum nachweis von urothelkarzinom
FR2894675B1 (fr) Distinction des meningites bacteriennes et virales
WO2006135775A3 (en) Rapid saccharide biomarker assay
WO2004085669A3 (en) Identification and quantification of microbial species in a sample
SE0602683L (sv) Diagnostisk metod
CY1115323T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
GB0501564D0 (en) Test for prion disease
HRP20200476T1 (hr) Prognostički postupak i pribor koristan za navedeni postupak